Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using cine MRI to detect abdominal adhesions

Official title: Sensitivity and Predictive Value of Functional Cine Magnetic Resonance Imaging (MRI) Detecting Intra-abdominal Adhesions

Run by Radboud University Medical Center · NCT00882167 · Data updated 2026-11-12

This study is testing if a special type of MRI can help find and map abdominal adhesions in patients who have had previous surgeries, to make future operations safer.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorRadboud University Medical Center
Academic / other
Locations5 sites (Arnhem, Gelderland and 4 other locations)
StatusRecruiting
StartedApril 2009
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedJanuary 15, 2025
Trial IDNCT00882167 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with a median abdominal scar from prior open abdominal surgeries measuring at least 10 cm.

Probably not a fit

Patients with severe claustrophobia or those for whom MRI is contraindicated will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the sensitivity and specificity of functional cine magnetic resonance imaging (MRI) in detecting and mapping intra-abdominal adhesions in patients who have undergone previous abdominal surgeries. By utilizing cineMRI, the study seeks to provide a non-invasive imaging technique that could help identify adhesions that may lead to complications during reoperations. The study will involve multiple centers and focus on patients with significant abdominal scarring. The primary outcome will measure how accurately cineMRI can detect adhesions compared to existing methods.

Why it matters

Potential benefit: If successful, this study could lead to improved imaging techniques that help prevent complications related to abdominal adhesions during surgeries.

How similar studies have gone: While the approach of using cineMRI for this purpose is novel, other imaging techniques have shown varying degrees of success in detecting adhesions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with a median abdominal scar due to a previous open abdominal surgical procedures with a length of at least 10 cm and have given written consent.

Exclusion Criteria:

* Severe claustrophobia.
* No MRI allowed

Where it's running

  • Radboud University Nijmegen Medical Center
    Nijmegen, Gelderland, Netherlands
    Recruiting
  • Rijnstate Hospital
    Arnhem, Gelderland, Netherlands
    Not yet recruiting
  • Jeroen Bosch Hospital
    's-Hertogenbosch, Netherlands
    Not yet recruiting
  • Gelre Hospital
    Apeldoorn, Netherlands
    Not yet recruiting
  • Catharina Hospital
    Eindhoven, Netherlands
    Not yet recruiting

Study contacts

  • Principal investigator: Richard PG ten Broek — Radboud University Nijmegen Medical Center
  • Study coordinator: Richard ten Broek
  • Email: r.tenbroek@chir.umcn.nl
  • Phone: +31243619493

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • How incretin treatments affect muscle mass and function in people with overweight or obesity

    This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.

    Recruiting Radboud University Medical Center · Amsterdam and 1 other locations · NCT07929831

  • Affordable, tailored physical therapy for financially vulnerable people after trauma

    We’re testing whether a patient-friendly, low-cost approach to physical therapy helps adults with trauma injuries who are financially vulnerable maintain or improve their quality of life.

    Recruiting Radboud University Medical Center · Nijmegen, Gelderland · NCT07795216

  • Timing of Immunotherapy in Melanoma

    This trial tests whether starting standard melanoma immunotherapy earlier in the day (before 10 am) versus later in the day (after 1 pm) makes a difference for patients with unresectable or metastatic melanoma.

    Recruiting Radboud University Medical Center · Amsterdam and 4 other locations · NCT07696715

  • Fiber to boost gut bacteria and immunotherapy response in advanced melanoma

    In people with advanced melanoma starting immunotherapy, this trial tests whether increasing dietary fiber can grow beneficial gut bacteria and improve treatment response.

    Recruiting Phase 2 Radboud University Medical Center · Nijmegen, Gelderland and 1 other locations · NCT07686835

  • Exercise to Boost Immunotherapy Response in Advanced Kidney Cancer

    In this pilot study, adults with advanced renal cell carcinoma receiving first-line nivolumab plus ipilimumab will try a supervised HIIT exercise program to see if it helps them better tolerate treatment and possibly improve immune and clinical outcomes.

    Recruiting at 2 sites Radboud University Medical Center · Arnhem, Gelderland and 1 other locations · NCT07680556

  • Modafinil for Debilitating Fatigue in Quiescent IBD

    A study will test whether modafinil can help adults with Crohn’s disease or ulcerative colitis who feel very fatigued even when their IBD is quiet.

    Recruiting at 2 sites Phase 2/3 Radboud University Medical Center · Arnhem, Gelderland and 1 other locations · NCT07582458

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.